Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06035835 |
Recruitment Status :
Completed
First Posted : September 13, 2023
Last Update Posted : September 13, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Atopic Dermatitis | Combination Product: Lacticaseibacillus rhamnosus Combination Product: Lactobacillus acidophilus + Bifidobacterium bifidum |
In this study, the investigators analyse the influence of nutrition during the early neonatal period on the development and prevention of atopic dermatitis (AD) in children with a history of very low birth weight (VLBW). A retrospective cohort study was performed of VLBW preterm infants to assess the risk of their developing AD during childhood, according to nutrition with breastmilk and/or probiotic supplementation during the neonatal period. The analysis focused on nutritional and early childhood follow-up data for 437 newborns, of whom 184 received probiotics up to 36 weeks postmenstrual age.
The neonatal history of the patients was consulted in their electronic medical records (gestacional age; birth weight; anthropometry at birth, first week and week 36 post menstrual age; nutricional management; administration of probiotics), and the presence of atopic diseases at school age was corroborated by telephone interviews.
The descriptive date were summarized using medians and interquartile intervals for the continuous variables and distribution frequencies for the categorial variables. Univariate comparisons were made by the Mann-Whitney test for the continuous variables and by the chi-square test for the categorical variables. The association of comorbidities in VLBW newborns and supplementation with one type or another of probiotic was evaluated with a multinomial regression analysis, ajustando por las variables que mostraron diferencias en el análisis de homogeneidad de los grupos de estudio. The analysis was performed using IBM SPSS 20.0 for Windows software
Study Type : | Observational |
Actual Enrollment : | 437 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Probiotics and Breastmilk Are Associated With a Decreased Risk of Atopic Dermatitis in Very Low Birth Weight Premature Infants |
Actual Study Start Date : | January 1, 2009 |
Actual Primary Completion Date : | December 31, 2021 |
Actual Study Completion Date : | March 2022 |
Group/Cohort | Intervention/treatment |
---|---|
Probiotic 1
Administration Lacticaseibacillus rhamnosus (L. Rhamnosus) ATCC 53103 (109 UFC/day) in very low birth weight since start at the first enteral feed until 35 week Postmenstrual age
|
Combination Product: Lacticaseibacillus rhamnosus
Administration Lacticaseibacillus rhamnosus (L. Rhamnosus) ATCC 53103 (109 UFC/day) |
Probiotic 2
Administration Lactobacillus acidophilus (L. acidophilus) ATCC 4356 (109 UFC/12 h)+Bifidobacterium bifidum (B. bifidum) ATCC 15696 (109 UFC/12 h) in very low birth weight since start at the first enteral feed until 35 week Postmenstrual age
|
Combination Product: Lactobacillus acidophilus + Bifidobacterium bifidum
Administration Lactobacillus acidophilus (L. acidophilus) ATCC 4356 (109 UFC/12 h)+Bifidobacterium bifidum (B. bifidum) ATCC 15696 (109 UFC/12 h) |
No probiotic
No suplementation diet with probiotic
|
- Change incidence of atopic dermatitis in children receiving probiotics [ Time Frame: From birth to January 2023 ]The investigators will assess the presence of atopic dermatitis (itching and chronic or recurrent eczematous lesions with typical morphology and distribution) in the telephone interview.
- To assess whether the combined use of breast milk and probiotics has a beneficial effect on the prevention of atopic dermatitis in children. [ Time Frame: From birth to January 2023 ]The investigators will ask patients for both attopic dermatitis involvement and a history of probiotic and breast milk administration in the neonatal period.
- Identify probiotic strains that may decrease the incidence of atopic dermatitis. [ Time Frame: From birth to January 2023 ]In the group of patients who received probiotics we found two groups, one group received Lacticaseibacillus rhamnosus ATCC 53103 and the other group received the combination of Lactobacillus acidophilus ATCC 4356 + Bifidobacterium bifidum ATCC 15696. An attempt will be made to identify if there are differences between them.
- Influence of caloric intake on the development of atopic dermatitis [ Time Frame: From birth to January 2023 ]The researchers will look at the medical history for caloric and macronutrient intake during the first weeks of life and assess whether it is related to differences in the development of atopic dermatitis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 32 Weeks (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Newborn with a gestational age < or = 32 weeks and/or birth weight < or = 1500 grams.
Exclusion Criteria:
- Incomplete health history record o lack of data.
- Severe congenital anomalies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06035835
Principal Investigator: | José Uberos-Fernández, Mr | Hospital Clinico Universitario San Cecilio |
Documents provided by José Uberos Fernández, Hospital Clinico Universitario San Cecilio:
Publications:
Responsible Party: | José Uberos Fernández, Head of Unit Care Neonatology, Principal Investigator, Clinical Professor, Hospital Clinico Universitario San Cecilio |
ClinicalTrials.gov Identifier: | NCT06035835 |
Other Study ID Numbers: |
BM-2022-12-0144.R2 |
First Posted: | September 13, 2023 Key Record Dates |
Last Update Posted: | September 13, 2023 |
Last Verified: | September 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Probiotics Human breastmilk newborn very low birth weight atopic eczema |
Dermatitis, Atopic Dermatitis Eczema Skin Diseases Skin Diseases, Genetic |
Genetic Diseases, Inborn Skin Diseases, Eczematous Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |